Remus Pharmaceuticals Limited (NSE:REMUS)
701.00
+44.00 (6.70%)
Feb 9, 2026, 3:26 PM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.